Oral GHK-Cu administration uses tablet-based pre-measured dosing rather than reconstitution-based dosing, simplifying protocol logistics
Storage Best Practices Proper storage is critical to maintaining bioactivity between research sessions
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
GHK-Cu consists of three amino acids glycine, histidine, and lysine complexed with a copper(II) ion
In animal research, it helps healing cells move to injured areas faster, supports new blood vessel growth, and reduces scar tissue